Investors

Privately Owned and Operated

INCELL is a privately owned and operated Texas limited liability corporation that is an emerging biopharmaceutical company. Founders hold the majority of shares but there are a few minority investors. Interested, ethical investors can call Dr. Mary Pat Moyer, President and CEO at 210-877-0100 or 800-364-1765 or send an email to mpmoyer@incell.com.

Funding and Revenue Categories

INCELL has multiple ongoing and planned funding and revenue categories as shown below.

Competitive Edge and a Lower Risk Investment

INCELL is seeking capital investment and strategic partners. The company has a Competitive Edge and is a Lower Risk Investment because it has:

• high levels of ethics and integrity in medical research and development as a core value

• high levels of ethics and integrity in fiscal management as a core value

• deep knowledge and subject matter expertise in relevant areas

• multiple lines of funding and revenues, including grants and contracts

• always had something to sell and has grown “organically” with sales of products and services, but minimal outside capital investment

• strong teams and leveraged synergies with collaborative partners

• strong assets, intellectual property and substantive product pipelines

• been in continuous operation since 1993

• benefitted from the substantial “sweat equity” of the majority owners

• frugal, cost containment, and responsible business practices